Urodynamic Systems in Utah

Utah Medical Products, Inc. is a specialized medical device manufacturer headquartered in Midvale, Utah, serving critical care, gynecology, neonatology, obstetrics, surgery, and urology markets. The company manufactures and distributes a range of specialty devices including gynecological surgical instruments (Filshie® Clip System for tubal ligation), obstetric catheters (CVX-Ripe® cervical ripening catheter, BT-Cath® balloon tamponade catheter for postpartum hemorrhage management), urological devices (Supra-Foley® suprapubic catheterization system), feeding catheters (Nutri-Cath® with ENFit™ enteral connections), and electrosurgical systems (Finesse®+ generators with integrated smoke evacuation). The company also markets the Liberty® Pelvic Floor Stimulation System for non-surgical treatment of urinary incontinence. Through its Femcare® subsidiary, Utah Medical is a recognized global leader in female surgical contraception. The company maintains relationships with more than 300 international distributors and demonstrates strong financial performance (2023: 59.8% gross profit margin, 33.1% net income margin). Utah Medical is committed to regulatory compliance and continuous quality improvement across its product portfolio, serving both hospital and office-based clinical settings.

BlueWind Medical manufactures Revi, an implantable neuromodulation device for the treatment of urge urinary incontinence (UUI). Revi is a miniature implant positioned near the ankle that delivers tibial nerve stimulation to modulate bladder control signals. The device is implanted during a single outpatient procedure under local anesthesia and offers personalized, patient-controlled therapy requiring as little as 30 minutes daily. Clinical data from the OASIS study (NCT03596671, 3-year follow-up) demonstrates 95% patient satisfaction and 79% of study completers achieving greater than 50% reduction in incontinence episodes. Revi represents a drug-free alternative to pharmacological and surgical interventions for overactive bladder. The company has received regulatory clearance and recognition, including the 2025 MedTech Breakthrough Award for Best New Technology Solution in Therapeutics. BlueWind's technology addresses a significant market of patients with urge incontinence, offering a reversible, minimally invasive solution with demonstrated long-term safety and efficacy profiles suitable for outpatient urology and continence specialty practices.

Advantage Urinal Systems, LLC manufactures non-invasive, self-emptying portable urinal systems designed for men, women, and children. The company's patented product line addresses urinary incontinence and relief without catheters, disposable briefs, or traditional hand-held urinals. The systems feature large-capacity removable reservoir bags with anti-reflux valves to prevent spillage and odor, ergonomic designs for gender-specific use, and easy-to-clean, durable construction. Products are marketed for both home care and care facilities, with emphasis on reducing fall risk, preventing urinary tract infections, maintaining bladder function, and reducing caregiver burden. The company emphasizes dignity, independence, and non-invasiveness as core benefits over catheterization and disposable alternatives. Products are reusable and positioned as cost-effective long-term solutions. The company operates a direct-to-consumer e-commerce model and targets aging populations, mobility-limited individuals, and institutional care settings. No specific FDA clearance or ISO certifications are mentioned on the fetched content.